Healthcare · Industry

Biotechnology - List & Prices (608 stocks)

By market cap Page 2 of 13 Prices: Oct 21, 2026 close Last Updated: Oct 21, 2026

Biotechnology - List & Prices
#	Company	Ticker	Price	Mkt cap	P/E	Div yield
51	PTC Therapeutics, Inc.	PTCT	$62.62	$5.23B	unprofitable	—
52	Erasca, Inc.	ERAS	$14.49	$5.07B	unprofitable	—
53	Travere Therapeutics, Inc.	TVTX	$52.58	$4.96B	unprofitable	—
54	CRISPR Therapeutics AG	CRSP	$50.50	$4.88B	unprofitable	—
55	Definium Therapeutics, Inc.	DFTX	$35.49	$4.77B	unprofitable	—
56	Tango Therapeutics, Inc.	TNGX	$26.98	$4.55B	unprofitable	—
57	Dianthus Therapeutics, Inc.	DNTH	$78.10	$4.37B	unprofitable	—
58	Edgewise Therapeutics, Inc.	EWTX	$39.65	$4.31B	unprofitable	—
59	Relay Therapeutics, Inc.	RLAY	$18.41	$4.03B	unprofitable	—
60	Arcutis Biotherapeutics, Inc.	ARQT	$31.87	$4.01B	138.6	—
61	AbCellera Biologics Inc.	ABCL	$12.24	$3.97B	unprofitable	—
62	Legend Biotech Corporation	LEGN	$18.63	$3.62B	unprofitable	—
63	Xenon Pharmaceuticals Inc.	XENE	$35.95	$3.48B	unprofitable	—
64	Acadia Pharmaceuticals Inc.	ACAD	$20.19	$3.48B	9.1	—
65	Parabilis Medicines, Inc.	PBLS	$27.85	$3.44B	unprofitable	—
66	IDEAYA Biosciences, Inc.	IDYA	$35.47	$3.42B	unprofitable	—
67	Telix Pharmaceuticals Limited	TLX	$10.03	$3.41B	100.3	—
68	Viking Therapeutics, Inc.	VKTX	$26.38	$3.35B	unprofitable	—
69	Tarsus Pharmaceuticals, Inc.	TARS	$70.50	$3.30B	unprofitable	—
70	Celcuity Inc. Common Stock	CELC	$61.56	$3.09B	unprofitable	—
71	Enliven Therapeutics, Inc.	ELVN	$41.82	$3.06B	unprofitable	—
72	Dyne Therapeutics, Inc.	DYN	$16.07	$3.00B	unprofitable	—
73	Denali Therapeutics Inc. Common Stock	DNLI	$18.68	$2.99B	unprofitable	—
74	Disc Medicine, Inc.	IRON	$76.00	$2.92B	unprofitable	—
75	Nurix Therapeutics, Inc.	NRIX	$26.02	$2.84B	10.7	—
76	Maravai LifeSciences Holdings, Inc.	MRVI	$7.57	$2.80B	unprofitable	—
77	Zai Lab Limited American Depositary Shares	ZLAB	$24.20	$2.72B	unprofitable	—
78	Viridian Therapeutics, Inc.	VRDN	$23.01	$2.61B	unprofitable	—
79	MBX Biosciences, Inc.	MBX	$53.93	$2.60B	unprofitable	—
80	Beam Therapeutics Inc.	BEAM	$24.84	$2.57B	unprofitable	—
81	NewAmsterdam Pharma Company N.V.	NAMS	$21.49	$2.51B	unprofitable	—
82	ADMA Biologics, Inc.	ADMA	$11.01	$2.47B	15.7	—
83	SELLAS Life Sciences Group, Inc.	SLS	$12.14	$2.45B	unprofitable	—
84	Arcus Biosciences, Inc.	RCUS	$19.10	$2.40B	unprofitable	—
85	Precigen, Inc.	PGEN	$6.60	$2.36B	unprofitable	—
86	Fortrea Holdings Inc.	FTRE	$24.06	$2.29B	unprofitable	—
87	Aurinia Pharmaceuticals Inc.	AUPH	$16.90	$2.25B	7.4	—
88	Vera Therapeutics, Inc.	VERA	$31.20	$2.25B	unprofitable	—
89	Harmony Biosciences Holdings, Inc.	HRMY	$38.31	$2.23B	12.4	—
90	Agios Pharmaceuticals, Inc.	AGIO	$37.18	$2.22B	unprofitable	—
91	Celldex Therapeutics, Inc.	CLDX	$29.37	$2.22B	unprofitable	—
92	Pharvaris N.V.	PHVS	$30.66	$2.15B	unprofitable	—
93	Immunome, Inc.	IMNM	$18.00	$2.12B	unprofitable	—
94	Vericel Corporation	VCEL	$40.94	$2.10B	87.1	—
95	Zymeworks Inc.	ZYME	$28.12	$2.02B	unprofitable	—
96	Lakefront Biotherapeutics NV	LKFT	$30.58	$2.00B	2.9	—
97	Sarepta Therapeutics, Inc.	SRPT	$18.56	$1.96B	unprofitable	—
98	Recursion Pharmaceuticals, Inc.	RXRX	$3.64	$1.95B	unprofitable	—
99	Septerna, Inc.	SEPN	$40.76	$1.90B	unprofitable	—
100	Xencor, Inc.	XNCR	$25.16	$1.87B	unprofitable	—

PTCT

PTC Therapeutics, Inc.

$62.62

Healthcare / Biotechnology

Market Cap: $5.23B
P/E: unprofitable

ERAS

Erasca, Inc.

$14.49

Healthcare / Biotechnology

Market Cap: $5.07B
P/E: unprofitable

TVTX

Travere Therapeutics, Inc.

$52.58

Healthcare / Biotechnology

Market Cap: $4.96B
P/E: unprofitable

CRSP

CRISPR Therapeutics AG

$50.50

Healthcare / Biotechnology

Market Cap: $4.88B
P/E: unprofitable

DFTX

Definium Therapeutics, Inc.

$35.49

Healthcare / Biotechnology

Market Cap: $4.77B
P/E: unprofitable

TNGX

Tango Therapeutics, Inc.

$26.98

Healthcare / Biotechnology

Market Cap: $4.55B
P/E: unprofitable

DNTH

Dianthus Therapeutics, Inc.

$78.10

Healthcare / Biotechnology

Market Cap: $4.37B
P/E: unprofitable

EWTX

Edgewise Therapeutics, Inc.

$39.65

Healthcare / Biotechnology

Market Cap: $4.31B
P/E: unprofitable

RLAY

Relay Therapeutics, Inc.

$18.41

Healthcare / Biotechnology

Market Cap: $4.03B
P/E: unprofitable

ARQT

Arcutis Biotherapeutics, Inc.

$31.87

Healthcare / Biotechnology

Market Cap: $4.01B
P/E: 138.6

ABCL

AbCellera Biologics Inc.

$12.24

Healthcare / Biotechnology

Market Cap: $3.97B
P/E: unprofitable

LEGN

Legend Biotech Corporation

$18.63

Healthcare / Biotechnology

Market Cap: $3.62B
P/E: unprofitable

XENE

Xenon Pharmaceuticals Inc.

$35.95

Healthcare / Biotechnology

Market Cap: $3.48B
P/E: unprofitable

ACAD

Acadia Pharmaceuticals Inc.

$20.19

Healthcare / Biotechnology

Market Cap: $3.48B
P/E: 9.1

PBLS

Parabilis Medicines, Inc.

$27.85

Healthcare / Biotechnology

Market Cap: $3.44B
P/E: unprofitable

IDYA

IDEAYA Biosciences, Inc.

$35.47

Healthcare / Biotechnology

Market Cap: $3.42B
P/E: unprofitable

TLX

Telix Pharmaceuticals Limited

$10.03

Healthcare / Biotechnology

Market Cap: $3.41B
P/E: 100.3

VKTX

Viking Therapeutics, Inc.

$26.38

Healthcare / Biotechnology

Market Cap: $3.35B
P/E: unprofitable

TARS

Tarsus Pharmaceuticals, Inc.

$70.50

Healthcare / Biotechnology

Market Cap: $3.30B
P/E: unprofitable

CELC

Celcuity Inc. Common Stock

$61.56

Healthcare / Biotechnology

Market Cap: $3.09B
P/E: unprofitable

ELVN

Enliven Therapeutics, Inc.

$41.82

Healthcare / Biotechnology

Market Cap: $3.06B
P/E: unprofitable

DYN

Dyne Therapeutics, Inc.

$16.07

Healthcare / Biotechnology

Market Cap: $3.00B
P/E: unprofitable

DNLI

Denali Therapeutics Inc. Common Stock

$18.68

Healthcare / Biotechnology

Market Cap: $2.99B
P/E: unprofitable

IRON

Disc Medicine, Inc.

$76.00

Healthcare / Biotechnology

Market Cap: $2.92B
P/E: unprofitable

NRIX

Nurix Therapeutics, Inc.

$26.02

Healthcare / Biotechnology

Market Cap: $2.84B
P/E: 10.7

MRVI

Maravai LifeSciences Holdings, Inc.

$7.57

Healthcare / Biotechnology

Market Cap: $2.80B
P/E: unprofitable

ZLAB

Zai Lab Limited American Depositary Shares

$24.20

Healthcare / Biotechnology

Market Cap: $2.72B
P/E: unprofitable

VRDN

Viridian Therapeutics, Inc.

$23.01

Healthcare / Biotechnology

Market Cap: $2.61B
P/E: unprofitable

MBX

MBX Biosciences, Inc.

$53.93

Healthcare / Biotechnology

Market Cap: $2.60B
P/E: unprofitable

BEAM

Beam Therapeutics Inc.

$24.84

Healthcare / Biotechnology

Market Cap: $2.57B
P/E: unprofitable

NAMS

NewAmsterdam Pharma Company N.V.

$21.49

Healthcare / Biotechnology

Market Cap: $2.51B
P/E: unprofitable

ADMA

ADMA Biologics, Inc.

$11.01

Healthcare / Biotechnology

Market Cap: $2.47B
P/E: 15.7

SLS

SELLAS Life Sciences Group, Inc.

$12.14

Healthcare / Biotechnology

Market Cap: $2.45B
P/E: unprofitable

RCUS

Arcus Biosciences, Inc.

$19.10

Healthcare / Biotechnology

Market Cap: $2.40B
P/E: unprofitable

PGEN

Precigen, Inc.

$6.60

Healthcare / Biotechnology

Market Cap: $2.36B
P/E: unprofitable

FTRE

Fortrea Holdings Inc.

$24.06

Healthcare / Biotechnology

Market Cap: $2.29B
P/E: unprofitable

AUPH

Aurinia Pharmaceuticals Inc.

$16.90

Healthcare / Biotechnology

Market Cap: $2.25B
P/E: 7.4

VERA

Vera Therapeutics, Inc.

$31.20

Healthcare / Biotechnology

Market Cap: $2.25B
P/E: unprofitable

HRMY

Harmony Biosciences Holdings, Inc.

$38.31

Healthcare / Biotechnology

Market Cap: $2.23B
P/E: 12.4

AGIO

Agios Pharmaceuticals, Inc.

$37.18

Healthcare / Biotechnology

Market Cap: $2.22B
P/E: unprofitable

CLDX

Celldex Therapeutics, Inc.

$29.37

Healthcare / Biotechnology

Market Cap: $2.22B
P/E: unprofitable

PHVS

Pharvaris N.V.

$30.66

Healthcare / Biotechnology

Market Cap: $2.15B
P/E: unprofitable

IMNM

Immunome, Inc.

$18.00

Healthcare / Biotechnology

Market Cap: $2.12B
P/E: unprofitable

VCEL

Vericel Corporation

$40.94

Healthcare / Biotechnology

Market Cap: $2.10B
P/E: 87.1

ZYME

Zymeworks Inc.

$28.12

Healthcare / Biotechnology

Market Cap: $2.02B
P/E: unprofitable

LKFT

Lakefront Biotherapeutics NV

$30.58

Healthcare / Biotechnology

Market Cap: $2.00B
P/E: 2.9

SRPT

Sarepta Therapeutics, Inc.

$18.56

Healthcare / Biotechnology

Market Cap: $1.96B
P/E: unprofitable

RXRX

Recursion Pharmaceuticals, Inc.

$3.64

Healthcare / Biotechnology

Market Cap: $1.95B
P/E: unprofitable

SEPN

Septerna, Inc.

$40.76

Healthcare / Biotechnology

Market Cap: $1.90B
P/E: unprofitable

XNCR

Xencor, Inc.

$25.16

Healthcare / Biotechnology

Market Cap: $1.87B
P/E: unprofitable

Showing 51–100 of 608 · ranked by market capitalization

Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.